Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation
- 1 February 1999
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Genetics & Development
- Vol. 9 (1), 49-54
- https://doi.org/10.1016/s0959-437x(99)80007-0
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Immunophilins in the Nervous SystemNeuron, 1998
- RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1Proceedings of the National Academy of Sciences of the United States of America, 1998
- Phosphorylation of the Translational Repressor PHAS-I by the Mammalian Target of RapamycinScience, 1997
- TOR2 is required for organization of the actin cytoskeleton in yeastProceedings of the National Academy of Sciences of the United States of America, 1996
- TOR controls translation initiation and early G1 progression in yeast.Molecular Biology of the Cell, 1996
- Control of p70 S6 kinase by kinase activity of FRAP in vivoNature, 1995
- TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycinCell, 1995
- Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progressionCell, 1993
- Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in YeastScience, 1991